✉news ScienceBiology first seen 4 d ago, last 4 d ago, peak #37
GeneDx adds long-read genome sequencing to boost rare disease diagnosis
Original: GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
GeneDx announced it is expanding into long-read genome sequencing, a technology it says will strengthen its rare disease diagnostics business and improve detection of complex genetic variants that short-read methods can miss. The company positions the move as extending its leadership in genome-based diagnostics for patients with unexplained rare conditions, a market where diagnostic yield has long been a key differentiator.
Why now: Long-read sequencing is an emerging technology with the potential to raise diagnostic rates for rare genetic diseases, making the announcement notable to clinicians, patients and investors.
Evidence
- GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis · Business Wire
API: https://socialmediatrends-api.osmike.com/v1/trends/2988178